Company: WHWK
Filing Date: 2025-08-07
Form Type: 10-Q
Source: 0000950170-25-105081
Chunk: 0

Company: Whitehawk Therapeutics, Inc.
Filing Date: 2025-08-07
Form: 10-Q
Item: Item 1
Chunk 0
---
WHITEHAWK THERAPEUTICS, INC.

Condensed Balance Sheets

(In thousands, except share data and par value)

(Unaudited)

     June 30,2025

     December 31,2024

     Assets

     Current assets:

     Cash and cash equivalents
      
     $
     144,936

     $
     28,670

     Short-term investments

     32,264

     18,567

     Accounts receivable, net

     —

     5,903

     Inventory

     —

     5,311

     Prepaid expenses and other current assets

     1,471

     2,836

     Total current assets

     178,671

     61,287

     Property and equipment, net

     9

     6,846

     Operating lease right-of-use assets

     —

     787

     Other assets

     2,142

     1,399

     Total assets
      
     $
     180,822

     $
     70,319

     Liabilities and stockholders’ equity

     Current liabilities:

     Accounts payable
      
     $
     3,339

     $
     2,159

     Accrued liabilities

     5,417

     14,647

     Operating lease liabilities, current portion

     —

     268

     Total current liabilities

     8,756

     17,074

     Operating lease liabilities, net of current portion

     —

     565

     Other liabilities

     —

     202

     Total liabilities

     8,756

     17,841

     Commitments and contingencies (Note 12)

     Stockholders’ equity:

     Preferred stock, $0.0001 par value, 10,000,000 shares authorized; no shares issued and outstanding as of June 30, 2025 and December 31, 2024

     —

     —

     Common stock, $0.0001 par value; 300,000,000 shares authorized; 47,128,362 and 24,680,708 shares issued and outstanding as of June 30, 2025 and December 31, 2024, respectively.

     4

     2

     Additional paid-in capital

     484,306

     385,114

     Accum